StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Verzenio — Worldwide revenue growth YoY by Quarter

Verzenio — Worldwide revenue growth YoY (%) (%)

QuarterlyAnnual

Eli Lilly Verzenio — Worldwide revenue growth YoY: -1.0% in Q2 2026, down 13.0 pts from a year earlier. That is the lowest of the 27 quarters on record here.

Latest, Q2 2026
-1.0%
Period ended Jun 30, 2026
Change on a year earlier
-13.0 pts
12.0% in Q2 2025
History
27 quarters
Since Q3 2019
Sources
27
Documents cited below

Where the Q2 2026 figure comes from

“|| Verzenio | 845 | 629 | 1,474 | 1,489 | (1)”

Source: Form 10-Q FY2026Q2 (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K MD&A & Form 8-K Releases.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedVerzenio — Worldwide revenue growth YoY (%) (%)Year on yearSource
Q2 2026Jun 30, 2026-1.0%-13.0 ptsForm 10-Q FY2026Q2 (filed 2026-08-05) ↗
Q1 2026Mar 31, 202612.0%+2.0 ptsForm 10-Q FY2026Q1 (filed 2026-04-30) ↗
Q4 2025Dec 31, 20253.0%-33.0 ptsEarnings Release (Form 8-K FY2025Q4 EX-99.1) (filed 2026-02-04) ↗
Q3 2025Sep 30, 20257.0%-25.0 ptsForm 10-Q FY2025Q3 (filed 2025-10-30) ↗
Q2 2025Jun 30, 202512.0%-32.0 ptsForm 10-Q FY2025Q2 (filed 2025-08-07) ↗
Q1 2025Mar 31, 202510.0%-30.0 ptsForm 10-Q FY2025Q1 (filed 2025-05-01) ↗
Q4 2024Dec 31, 202436.0%-6.0 ptsEarnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗
Q3 2024Sep 30, 202432.0%-36.0 ptsForm 10-Q FY2024Q3 (filed 2024-10-30) ↗
Q2 2024Jun 30, 202444.0%-13.0 ptsForm 10-Q FY2024Q2 (filed 2024-08-08) ↗
Q1 2024Mar 31, 202440.0%-20.0 ptsForm 10-Q FY2024Q1 (filed 2024-04-30) ↗
Q4 2023Dec 31, 202342.0%-58.0 ptsEarnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 202368.0%-16.0 ptsForm 10-Q FY2023Q3 (filed 2023-11-02) ↗
Q2 2023Jun 30, 202357.0%-15.0 ptsForm 10-Q FY2023Q2 (filed 2023-08-08) ↗
Q1 2023Mar 31, 202360.0%-14.0 ptsForm 10-Q FY2023Q1 (filed 2023-04-27) ↗
Q4 2022Dec 31, 2022100.0%+57.0 ptsEarnings Release (Form 8-K FY2022Q4 EX-99.1) (filed 2023-02-02) ↗
Q3 2022Sep 30, 202284.0%+41.0 ptsForm 10-Q FY2022Q3 (filed 2022-11-01) ↗

Cite this data

StockData. (2026). Eli Lilly Verzenio — Worldwide revenue growth YoY (%), quarterly Q3 2019–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-verzenio-yoy

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.